FEB 20, 2017 08:00 AM PST

High throughput process development - optimizing a mAb chromatography polishing step

Speakers
  • Product Manager Design, GE Healthcare Life Sciences
    Biography
      Peter Hagwall has a scientific background in process analytical technologies and surface chemistry. For the last 5 years, Peter has been active as product manager for chromatography resins and focus on tools and methodologies for process development and characterization

    Abstract:

    Development of robust purification processes requires significant time and resources. In addition, steadily increasing demands from regulatory authorities for better understanding and control of manufacturing processes put even more pressure on development work. High-throughput process development (HTPD) shortens development time at the same time as it increases the amount of information available during early process development.

    Here we will present a case study using high throughput process development tools optimizing process conditions for a mAb polishing step using a multimodal chromatography resin (Capto MMC ImpRes)


    Show Resources
    You May Also Like
    AUG 30, 2018 11:00 AM EDT
    C.E. CREDITS
    AUG 30, 2018 11:00 AM EDT
    DATE: August 30, 2018TIME: 11:00am EDT, 5:00pm CEST The need to quantify urine is valuable because it provides information on chemicals that the body makes naturally, as well...
    AUG 30, 2018 10:00 AM CEST
    C.E. CREDITS
    AUG 30, 2018 10:00 AM CEST
    DATE: August 30, 2018TIME:  10:00am CEST, 4:00pm CST The need to quantify urine is valuable because it provides information on chemicals that the body makes naturall...
    MAY 22, 2018 08:00 AM PDT
    C.E. CREDITS
    MAY 22, 2018 08:00 AM PDT
    DATE: May 22, 2018TIME: 08:00AM PDT The nuclear receptors pregnane X receptor (PXR) and constitutive androstane receptor (CAR) are closely related transcription factors that...
    JUN 28, 2017 07:00 AM PDT
    JUN 28, 2017 07:00 AM PDT
    DATE: June 28, 2017TIME: 7:00am PT, 10am ETAs gene therapy approaches usually require large amounts of AAV vectors for clinical use, few manufacturing processes have been repo...
    OCT 19, 2017 08:00 AM PDT
    C.E. CREDITS
    OCT 19, 2017 08:00 AM PDT
    DATE: October 19, 2017TIME: 08:00am PDT, 11:00am EDT Recent FDA approval of the first Chimeric Antigen Receptor T cell (CAR-T) therapy offers cancer patients more promise than...
    NOV 15, 2018 10:00 AM PST
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    C.E. CREDITS
    NOV 15, 2018 10:00 AM PST
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    DATE:  November 15, 2018TIME:  10:00am PT, 1:00pm ET Multiplex fluorescence immunohistochemistry offers a window into the biology of human disease, enabling the ana...
    Loading Comments...